群狼谷全国论坛春风阁(全国信息),泻火楼论坛,新qm论坛,良家论坛一品楼

　　In order to standardize and guide the study and evaluation of nano drugs, under the deployment of the National Medical Products Administration, the Center for Drug Evaluation has organized to formulate the Technical Guidance for Quality Control Study of Nano Drugs (interim), Technical Guidance for Non-Clinical Pharmacokinetic Study of Nano Drugs (interim), and Technical Guidance for Non-Clinical Safety Evaluation Study of Nano Drugs (interim), which were issued and implemented on August 27, 2021 upon review and approval by the National Medical Products Administration.

　　(August 27, 2021)